Cape Town Oncology Trials

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Melanoma2 trials
• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Bayer1 trial
• Bristol-Myers Squibb1 trial
• Eikon Therapeutics1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  NCT06697301· Phase 2/3· Eikon Therapeutics· Source

  Contact: Theo Niemand

• Recruiting

  A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  NCT06561386· Phase 3· Bristol-Myers Squibb· Source

  Contact: Corlia Coetzee, Site 0428

• Active, not recruiting

  Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

  NCT05352672· Phase 3· Regeneron Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting

Closed trials

• Completed

  Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

  NCT04736199· Phase 3· Bayer· Source